PEAK6
ASND icon

PEAK6’s Ascendis Pharma A/S ASND Stock Holding History

PEAK6’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,000
Closed -$2.29M – 2715
2026
Q1 		$2.29M Hold
10,000
– – 0.01% 1310
2025
Q4 		$2.13M Buy
+10,000
New +$2.07M ﹤0.01% 1404

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

PEAK6's ASND Position: Q2 2026 in Review

PEAK6 opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 3,764 shares worth $1M. The stake represents ﹤0.01% of the portfolio and ranks #1693 among its holdings. This is a return to the name: PEAK6 previously reported a position in ASND as recently as Q4 2025.

PEAK6 first reported a position in ASND in Q4 2025 and has held it in 2 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • PEAK6 held 3,764 shares of Ascendis Pharma A/S worth $1M as of Q2 2026.
  • Ascendis Pharma A/S was a new PEAK6 position in Q2 2026.
  • Ascendis Pharma A/S made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #1693 holding.
  • PEAK6 first reported a position in Ascendis Pharma A/S in Q4 2025 and has held it in 2 quarters since.
  • 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.